Carcinoid Tumour

17,996 views 31 slides Feb 22, 2014
Slide 1
Slide 1 of 31
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31

About This Presentation

No description available for this slideshow.


Slide Content

Carcinoid Carcinoid
TumoursTumours
Dr. Ahmed AlmumtinDr. Ahmed Almumtin

IntroductionIntroduction
The term The term “carcinoid” “carcinoid”
““Carcinoid syndrome” vs “carcinoid tumour”Carcinoid syndrome” vs “carcinoid tumour”

EpidemiologyEpidemiology
Carcinoids are relatively rare tumors.Carcinoids are relatively rare tumors.
incidence 4.7:100,000incidence 4.7:100,000
median age 63median age 63
male : femalemale : female
is it really increasing?is it really increasing?

DistributionDistribution

Pathology and gradingPathology and grading
Origin.Origin.
Different behaviour.Different behaviour.
Grading vs differentiation.Grading vs differentiation.
Two sub-Groups:Two sub-Groups:
Well differentiatedWell differentiated
Poorly differentiated Poorly differentiated

Embryonic classificationEmbryonic classification
Based on Embryonic originBased on Embryonic origin
Foregut - stomachForegut - stomach
Midgut - Small intestine, AppendixMidgut - Small intestine, Appendix
Hindgut - Colon, Rectum, Genitourinary, Hindgut - Colon, Rectum, Genitourinary,
Ovarian ..Ovarian ..
MetastaticMetastatic

TeTe
xtxt
- Well differentiated:- Well differentiated:
•Low gradeLow grade
•Intermediate GradeIntermediate Grade
- Poorly differentiated- Poorly differentiated
•High gradeHigh grade
WHO ClassificationWHO Classification

Continue classificationContinue classification
European Neuroendocrine Tumour Society European Neuroendocrine Tumour Society
(ENTS) vs American Joint Committee on (ENTS) vs American Joint Committee on
Cancer (AJNCC) vs WHO.Cancer (AJNCC) vs WHO.

Carcinoid syndromeCarcinoid syndrome

Carcinoid SyndromeCarcinoid Syndrome
DefinitionDefinition
Pathophysiology - mediatorsPathophysiology - mediators
Tryptophan MetabolismTryptophan Metabolism
HistamineHistamine
KillekrienKillekrien
ProstaglandinsProstaglandins
TachykininsTachykinins
Clinical featuresClinical features

Clinical Features of Clinical Features of
carcinoid syndromecarcinoid syndrome
Cutaneous flushingCutaneous flushing
Venous Venous
telangiectasiatelangiectasia
diarrhoeadiarrhoea
bronchospasmbronchospasm
cardiac valvular cardiac valvular
lesionslesions

So, patient presentsSo, patient presents
as a result of the carcinoid as a result of the carcinoid
syndromesyndrome
or as a result of tumour growthor as a result of tumour growth
or as incidental findingor as incidental finding

DiagnosisDiagnosis
Biochemical testing:Biochemical testing:
Urinary 5-HIAAUrinary 5-HIAA
Urinary SerotoninUrinary Serotonin
serum chromograninserum chromogranin
Serum serotonin Serum serotonin
Tumour localisationTumour localisation
CTCT
MRIMRI
Scintigraphy OctreoScanScintigraphy OctreoScan
PET scanPET scan
EndoscopyEndoscopy

Basic principles of evaluation and Basic principles of evaluation and
management of patients with management of patients with
carcinoid tumourscarcinoid tumours
Radiographic Staging and LocalisationRadiographic Staging and Localisation
Pathologic assessment of tumour differentiation Pathologic assessment of tumour differentiation
and/or gradeand/or grade
Removal of TumourRemoval of Tumour
Control of carcinoid symptomsControl of carcinoid symptoms

Treatment of Localised Treatment of Localised
CarcinoidsCarcinoids
- Appendix- Appendix
- Small intestine- Small intestine
- Rectum- Rectum
- Colon- Colon
- Stomach- Stomach

AppendixAppendix
SizeSize
>2 cm>2 cm
< 2cm< 2cm
Appendectomy vs Rt Appendectomy vs Rt
hemicolectomyhemicolectomy

Small intestineSmall intestine
Usual location.Usual location.
MatastasisMatastasis
prognosisprognosis

RectumRectum
TreatmentTreatment
< 1 cm mucosa or < 1 cm mucosa or
submucosasubmucosa
> 2 cm or beyond > 2 cm or beyond
muscolaris propriamuscolaris propria
PrognosisPrognosis

ColonColon
AggressiveAggressive
5 years survival5 years survival
prognosisprognosis

StomachStomach
TypesTypes
optionsoptions
Medical therapy?Medical therapy?

PrognosisPrognosis
Stage and Site of originStage and Site of origin
Tumour differentiationTumour differentiation

Post-treatment F/UPost-treatment F/U
Gastric, Small intestine, Colonic, appendiceal Gastric, Small intestine, Colonic, appendiceal
and Rectaland Rectal
3 to 12 months..3 to 12 months..
more than one yearmore than one year
Gastric <= 2 cmGastric <= 2 cm

TeTe
xtxt
Thank youThank you